Amarin Corp Plc (AMRN)

[MedResCollab]

"Biobillionair",

It would be a mistake for Amarin to push the EPA:AA ratio idea, especially with the angle that it was this that had anything to do with a reduction in ASCVD, as it is very easy to move the needle of that ratio in EPA's favor by eating a lot of fish, or taking a cheap fish oil supplement with a high percentage of EPA in it. Why do you think they have been silent about that? STRENGTH might even read out with higher EPA levels in its active arm subjects than those treated with Vascepa in REDUCE-IT.